Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories to Webcast Investor Meeting

WILMINGTON, Mass.--(BUSINESS WIRE)--Dec. 12, 2005--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that management will hold a meeting for the investment community on Wednesday, December 14, 2005. Investors as well as the general public are invited to listen to a live webcast of the meeting which is scheduled to begin at 8:30 a.m. and is expected to last until 11:30 a.m. E.T.

A live webcast will be available through a link that will be posted on the Investor Relations section of the Charles River Laboratories website, http://ir.criver.com. A replay of the webcast will be accessible through the same website approximately three hours after the presentation and will remain available until December 21, 2005.

CONTACT: Charles River Laboratories International, Inc.
Susan E. Hardy, 781-262-7616

SOURCE: Charles River Laboratories International, Inc.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)